Grainger
At a time when UK property shares are still recovering from higher interest rates and policy uncertainty, Grainger’s latest trading update offers reassurance. Rents are rising steadily, homes remain largely full, and new developments continue to be delivered into a market where rental demand still exceeds supply. Against a
Company Analysis
Shares in Ramsdens Holdings have risen sharply over the past year, alongside a clear improvement in both turnover and profitability. The business appears to be in much better shape than it was, but the key question for investors is whether the shares now offer a good entry point or whether
Company Analysis
SkinBioTherapeutics has not explicitly disclosed a £750k Zenakine royalty figure in its FY25 accounts, with commercial terms remaining confidential. However, the CEO has publicly acknowledged that straightforward arithmetic using figures in the annual report allows this amount to be inferred as attributable to Zenakine royalties. At first glance, a number
